XML 21 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flow from operating activities:    
Net loss $ (15,236) $ (19,882)
Adjustments to reconcile net loss to cash used in operations:    
Depreciation and amortization 1,254 1,214
Stock-based compensation 2,508 1,498
Charge to allowance for credit losses 517 326
Non-cash operating lease costs 735 1,087
Non-cash interest 63 27
Changes in operating assets and liabilities:    
Accounts receivable (10,786) (2,908)
Other current assets (4,391) 123
Other long-term assets (40) 12
Accounts payable 3,829 1,283
Accrued expenses and other 3,578 995
Deferred revenue (67) (317)
Operating lease liabilities (758) (1,158)
Net cash used in operating activities (18,794) (17,700)
Cash flow from investing activities:    
Purchases of property, equipment and capitalized internal-use software development costs (2,335) (1,387)
Net cash used in investing activities (2,335) (1,387)
Cash flow from financing activities:    
Proceeds from debt 0 23,302
Repayment of debt 0 (6,302)
Proceeds from public offering, net of underwriting discounts and commissions and other offering costs 219,819 0
Proceeds from exercise of stock options 1,598 279
Net proceeds from the issuance of redeemable convertible preferred stock 0 56,936
Repurchase of common stock related to net share settlement (296) (85)
Principal payments on finance lease obligations (83) (79)
Net cash provided by financing activities 221,038 74,051
Net increase in cash: 199,909 54,964
Cash & cash equivalents at beginning of period 58,569 23,224
Cash & cash equivalents at end of period 258,478 78,188
Supplemental disclosure:    
Cash paid for interest 66 312
Cash paid for taxes 64 70
Non-cash investing and financing activities:    
Accretion of preferred stock to redemption value 56 67
Conversion of preferred stock to common stock upon initial public offering 160,857 0
Costs related to initial public offering included in accounts payable and accrued liabilities $ 292 $ 0